Addison disease and Cushing syndrome are both disorders of the adrenal glands and hypothalamic-pituitary-adrenal (HPA) axis, but they represent opposite ends of cortisol physiology. Addison disease, or primary adrenal insufficiency, stems from inadequate cortisol and often aldosterone production due to adrenal damage, leading to fatigue, hyponatremia, hyperpigmentation, and orthostatic hypotension. In contrast, Cushing syndrome reflects prolonged cortisol excess, frequently from exogenous glucocorticoid use, but can also arise from pituitary or adrenal sources, causing central obesity, skin fragility, hypertension, and glucose intolerance. This article outlines their definitions, causes, clinical features, diagnostic workup, and management to clarify how these two conditions differ and how they relate within the spectrum of cortisol disorders.
Defining Addison Disease and Cushing Syndrome
Addison disease is primary adrenal insufficiency in which the adrenal cortex is damaged and cannot produce sufficient cortisol and typically also aldosterone. Common causes include autoimmune adrenalitis, tuberculosis, fungal infections, adrenal hemorrhage, and metastatic disease. When cortisol demand rises, such as during illness or stress, the body cannot mount an appropriate response, leading to acute presentations such as adrenal crisis.
Cushing syndrome encompasses any condition that causes prolonged exposure of tissues to excess cortisol. This may be due to exogenous corticosteroid use (most commonly iatrogenic Cushing syndrome), a pituitary adenoma secreting adrenocorticotropic hormone (ACTH-dependent Cushing disease), or an adrenal tumor autonomously producing cortisol (ACTH-independent). Although the underlying causes vary, the clinical picture often overlaps, centered on signs of glucocorticoid excess and metabolic derangement.
Shared Pathophysiology, Opposing Hormone States
Both conditions involve disruption of the HPA axis, but in opposite directions. In Addison disease, cortisol deficiency leads to reduced negative feedback on the hypothalamus and pituitary, which increases corticotropin-releasing hormone and ACTH, driving melanocyte stimulation and hyperpigmentation. In Cushing syndrome, elevated cortisol provides strong negative feedback, suppressing ACTH; if the cause is exogenous glucocorticoids or an adrenal tumor, ACTH is typically low, whereas in Cushing disease the pituitary adenoma drives inappropriately high ACTH.
These hormonal dynamics explain many of the clinical distinctions: Addison disease commonly features hyponatremia, hyperkalemia, hypotension, and skin hyperpigmentation, whereas Cushing syndrome is associated with hyperglycemia, hypertension, central obesity, and skin atrophy. Recognizing these patterns is essential for timely diagnosis and appropriate referral to endocrinology.
Clinical Presentations Compared
The clinical manifestations of Addison disease and Cushing syndrome can appear gradually or acutely, depending on the speed of cortisol change and the presence of precipitating stressors. In Addison disease, symptoms often develop insidiously and may include chronic fatigue, anorexia, weight loss, nausea, vomiting, abdominal pain, muscle weakness, and postural dizziness. Physical examination may reveal hyperpigmentation of the skin and mucous membranes, particularly in sun-exposed areas, surgical scars, and pressure points. Acute adrenal crisis presents with severe hypotension, dehydration, hyponatremia, hyperkalemia, and altered mental status, requiring urgent treatment with intravenous hydrocortisone and fluid resuscitation.
In contrast, Cushing syndrome commonly presents with a constellation of signs related to cortisol excess. Patients may note progressive weight gain with a characteristic fat redistribution pattern, facial rounding (moon facies), dorsocervical or supraclavicular fat pads (buffalo hump), and truncal obesity with relatively spared extremities. Skin changes include thinning, easy bruising, purple striae, and impaired wound healing. Other features include hypertension, new-onset or worsening diabetes, muscle weakness, osteoporosis, mood changes, and, in some cases, menstrual irregularities or hirsutism in women.
Presentation at Extremes of Age
In children, untreated Addison disease can cause failure to thrive, delayed puberty, and hypoglycemia, whereas pediatric Cushing syndrome may manifest as growth failure despite weight gain and early pubarche due to androgen excess. In older adults, both conditions may present with subtle changes, such as weakness, falls, or glucose intolerance, making a high index of suspicion necessary. Clinicians should consider underlying etiology, as adrenal or pituitary tumors become more common with advancing age and can influence management decisions.
Diagnostic Evaluation
Diagnosis begins with a careful history and physical examination, paying attention to medication use, symptom onset, and characteristic physical findings. Initial laboratory assessment typically includes morning serum cortisol and adrenocorticotropic hormone (ACTH) levels. In Addison disease, morning cortisol is low and ACTH is elevated, reflecting primary adrenal failure. In Cushing syndrome, morning cortisol is usually elevated, and the next step often involves confirmation with a low-dose dexamethasone suppression test or 24-hour urinary free cortisol measurement, followed by differentiation of the cause with high-dose dexamethasone testing or measurement of ACTTH levels.
| Parameter | Addison Disease | Cushing Syndrome |
|---|---|---|
| Morning serum cortisol | Low | Elevated |
| Plasma ACTH | Elevated (primary) | Variable: high (ACTH-dependent) or low (ACTH-independent) |
| Sodium | Often low (hyponatremia) | Often normal or high |
| Potassium | Often high (hyperkalemia) | Often normal or low |
| Blood pressure | Often low (hypotension) | Often elevated (hypertension) |
| Key imaging | Adrenal imaging (CT or MRI); pituitary imaging if indicated | Pituitary MRI (if ACTH-dependent); adrenal imaging if ACTH-independent |
Management and Treatment Approaches
Management of Addison disease focuses on cortisol and, when deficient, aldosterone replacement to mimic normal physiology and prevent adrenal crisis. Hydrocortisone is typically used as the glucocorticoid replacement, with dosing divided into a higher morning dose and a lower afternoon or evening dose to align with circadian rhythm. Fludrocortisone is used for mineralocorticoid replacement as needed, guided by clinical status, renin-aldosterone levels, and blood pressure. Patients are educated regarding sick-day rules, stress-dose hydrocortisone during illness or surgery, and the use of emergency injectable glucocorticoids. Long-term follow-up monitors for comorbidities such as autoimmune polyglandular syndromes and optimizes quality of life.
Treatment of Cushing syndrome is tailored to the underlying cause. If iatrogenic, the approach involves gradual tapering of glucocorticoids when feasible and implementing strategies to minimize glucocorticoid-induced adverse effects, including bone protection, glycemic control, and cardiovascular risk management. For Cushing disease due to a pituitary adenoma, transsphenoidal surgery is often first-line, sometimes followed by medical therapy or radiation if remission is not achieved. Adrenal tumors may be managed with surgical resection and appropriate steroid replacement postoperatively. Successful treatment often requires an interdisciplinary team to address metabolic complications, mental health, and cardiovascular risk.
Differential Diagnosis and Overlap
Clinically, some patients may have subtle or evolving features that do not fit classic presentations. For example, individuals on chronic glucocorticoids may develop features resembling both Cushing syndrome and, upon withdrawal, a reversible adrenal insufficiency until hypothalamic-pituitary-adrenal function recovers. Rare causes, such as ectopic ACTH secretion, can produce mixed or atypical phenotypes. A high index of suspicion, careful medication review, and targeted endocrine testing help clarify the diagnosis. When in doubt, endocrinology consultation can guide testing and ensure accurate phenotyping of the HPA axis dysfunction.
Practical Considerations for Patients and Clinicians
- Medication review is essential: document all glucocorticoid exposures, including topical, inhaled, and systemic forms.
- Educate patients with Addison disease about stress-dose steroids and emergency protocols; provide medical alert identification.
- In suspected Cushing syndrome, obtain a detailed medication list before pursuing imaging or invasive testing.
- Monitor metabolic parameters regularly: glucose, blood pressure, bone density, and electrolytes in both conditions.
- Coordinate care with endocrinology, especially when etiology is complex or requires surgical evaluation.
Summary and Key Takeaways
Addison disease and Cushing syndrome represent contrasting states of cortisol physiology: deficiency versus excess. While their causes and some features differ, both can profoundly affect quality of life and require accurate diagnosis and individualized management. Recognizing the hallmark clinical patterns, interpreting cortisol and ACTH in context, and pursuing timely endocrine referral when indicated are central to safe, effective care. Understanding these distinctions helps clinicians communicate clearly with patients, set realistic expectations, and coordinate long-term follow-up across comorbidities.